Grape seed proanthocyanidin extract has potent anti-arthritic effects on collagen-induced arthritis by modifying the T cell balance

International Immunopharmacology

Volumn 17, Issue 1, 2013, Pages 79-87

  Ahmad, Sheikh Fayaz ^a   Zoheir, Khairy M A ^a,d   Abdel Hamied, Hala E ^b   Ashour, Abdelkader E ^a   Bakheet, Saleh A ^a   Attia, Sabry M ^a,c   Abd Allah, Adel R A ^a,c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b AL AZHAR UNIVERSITY   (Egypt)

^c Al Azhar University   (Egypt)

^d NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Adjuvant induced arthritis (AIA) model; Arthritis; Cytokines; Grape seed proanthocyanidin extract; Inflammatory mediators; T regulatory cells

Indexed keywords

ANTIRHEUMATIC AGENT; CXCL3 CHEMOKINE; GAMMA INTERFERON; GRAPE SEED EXTRACT; GRAPE SEED PROANTHOCYANIDIN EXTRACT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROANTHOCYANIDIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANKLE; ARTHRITIS; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SYNOVIOCYTE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 TH2 BALANCE;

EID: 84879241278     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.05.026     Document Type: Article

References (45)

1. Ouaked N, Mantel PY, Bassin C, Burgler S, Siegmund K, Akdis CA, et al. Th1 cytokines: the role of regulation of the foxp3 gene by the TH1 cytokines: the role of IL-27-induced STAT1. J Immunol 2009;182:1041-9.
2. Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007;148:32-46. (Pubitemid 46365005)
3. Niu Q, Huang ZC, Cai B, Wang LL, Feng WH. Study on ratio imbalance of peripheral blood Th17/Treg cells in patients with rheumatoid arthritis. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2010;26:267-72.
4. Esenten JH, Wofsy D, Bluestone JA. Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol 2009;5:560-5.
5. Lotz M, Kekow J, Carson DA. Transforming growth factor-beta and cellular immune responses in synovial fluids. J Immunol 1990;144:4189-94. (Pubitemid 20187756)
6. Moore KW, O'Garra A, De Waal-Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-90. (Pubitemid 23115005)
7. Vannier E, Miller LC, Dinarello CA. Coordinated anti-inflammatory effects of interleukin-4: IL-4 suppresses IL-1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci U S A 1992;89:4076-80.
8. Fine AM. Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications. Altern Med Rev 2000;5:144-51. (Pubitemid 30226470)
9. Bagchi D, Bagchi M, Stohs SJ, Ray SD, Sen CK, Preuss HG. Cellular protection with proanthocyanidins derived from grape seeds. Ann N Y Acad Sci 2002;957:260-70. (Pubitemid 34721670)
10. Zhang YY, Li WG, Wu YJ, Bai DC, Liu NF. Proanthocyanidin from grape seeds enhances doxorubicin-induced antitumor effect and reverses drug resistance in doxorubicin-resistant K562/DOX cells. Can J Physiol Phamacol 2005;83:309-18.
11. Mi-La C, Yu-Jung H, Mi-Kyung P, Hye-Jwa O, Jin-Sil P, Yun-Ju W, et al. Grape seed proanthocyanidin extract (GSPE) attenuates collagen-induced arthritis. Immunol Lett 2009;124:102-10.
12. Mi-Kyung P, Jin-Sil P, Mi-La C, Hye-Jwa O, Yu-Jung H, Yun-Ju W, et al. Grape seed proanthocyanidin extract (GSPE) differentially regulates Foxp3+ regulatory and IL-17+ pathogenic T cell in autoimmune arthritis. Immunol Lett 2011;135:50-8.
13. Moudgil KD, Chang TT, Eradat H, Chen AM, Gupta RS, Brahn E, et al. Diversification of T cell responses to carboxy-terminal determinants within the 65-kD heat-shock protein is involved in regulation of autoimmune arthritis. J Exp Med 1997;185:1307-16. (Pubitemid 27172911)
14. Ahmad SF, Khan B, Bani S, Suri KA, SattiNK,Qazi GN.Amelioration of adjuvant-induced arthritis by ursolic acid through altered Th1/Th2 cytokine production. Pharmacol Res 2006;53:233-40. (Pubitemid 43247535)
15. Lee EY, Lee CK, Lee KU, Park JY, Cho KJ, Cho YS. Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice. Rheumatol Int 2007;27:225-33. (Pubitemid 46088252)
16. Canter PH, Wider B, Ernst E. The antioxidant vitamins A, C, E and selenium in the treatment of arthritis: a systematic review of randomized clinical trials. Rheumatology (Oxford) 2007;46:1223-33. (Pubitemid 47244491)
17. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007;7:429-42. (Pubitemid 46834849)
18. Raza K, Falciani F, Curnow SJ. Early rheumatoid arthritis is characerized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005;7:784-95.
19. Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007;8:950-7.
20. Cao D, Vollenhoven Rvan, Klareskog L, Trollmo C, Malmstrom V. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 2004;6:R335-46.
21. Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996;26:1511-8.
22. Baecher-Allan C, Viglietta V, Hafler DA. Human CD4+CD25+ regulatory T cells. Semin Immunol 2004;16:89-97. (Pubitemid 38234760)
23. Dombrecht EJ, Aerts NE, ASchuerwegh J, Hagendorens MM, Ebo DG, Van Offel JF, et al. Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis. Clin Exp Rheumatol 2006;24: 31-7.
24. Nocentini G, Riccardi C. A multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur J Immunol 2005;35(4):1016-22. (Pubitemid 40542207)
25. Shevach EM, Stephens GL. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 2006;6:613-8. (Pubitemid 44134094)
26. Ji HB, Liao G, Faubion WA, Abadia-Molina AC, Cozzo C, Laroux FS, et al. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J Immunol 2004;172:5823-7. (Pubitemid 38621178)
27. Stephens GL, McHugh RS, Whitters MJ, Young DA, Luxenberg D, Carreno BM, et al. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 2004;173:5008-20. (Pubitemid 39387783)
28. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-61. (Pubitemid 36222930)
29. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775-87. (Pubitemid 351707693)
30. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004;200:277-85. (Pubitemid 39031247)
31. Aarvak T, Chabaud M, Kallberg E, Miossec P, Natvig JB. Change in the Th1/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium. Scand J Immunol 1999;50:1-9. (Pubitemid 29298019)
32. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344(12):907-16. (Pubitemid 32224400)
33. Kagari T, Doi H, Shimozato T. The importance of IL-1 beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J Immunol 2002;169(3):1459-66. (Pubitemid 34809191)
34. Borzi RM, Mazzetti I, Cattini L, Uguccioni M, Baggiolini M, Facchini A. Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheum 2000;43: 1734-41.
35. Ogata H, Takeya M, Yoshimura T, Takagi K, Takahashi K. The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats. J Pathol 1997;182(1):106-14. (Pubitemid 27240456)
36. Kunkel SL, Lukacs N, Kasama T, Strieter RM. The role of chemokines in inammatory joint disease. J Leukocyte Biol 1996;59:6-12. (Pubitemid 26054588)
37. Taylor PC, Feldmann M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol 2009;5(10):578-82.
38. Sakurada S, Kato T, Okamoto T. Induction of cytokines and ICAM-1 by pro-inflammatory: Induction of cytokines and ICAM-1 by pro-inflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-L-cysteine and aspirin. Intern Immunol 1996;8:1483-93. (Pubitemid 26341088)
39. KirkhamBW, Lassere MN, Edmonds JP, Juhasz KM, Bird PA, Lee CS, et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum 2006;54:1122-31. (Pubitemid 43672925)
40. Lubberts E, Joosten LA, Oppers B, van den BL, Coenen-de RCJ, Kolls JK, et al. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 2001;167:1004-13. (Pubitemid 32660858)
41. Massague J, Blain SW, Lo RS. TGFß signaling in growth control, cancer, and heritable disorders. Cell 2000;103:295-309.
42. Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, et al. Reciprocal IFN-? and TGF-ß responses regulate the occurrence of mucosal inflammation. Immunol Today 1997;18:61-4. (Pubitemid 27107097)
43. Shull MM, Ormsby I, Kier AB. Targeted disruption of the mouse transforming growth factor-ß1 gene results in multifocal inflammatory disease. Nature 1992;359:693-9.
44. Yeh L, Augustine AJ, Lee P, Riviere LR, Sheldon A. Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants. J Rheumatol 1995;22:1740-6.
45. Joosten LA, Lubberts E, Durez P, Helsen MM, Jacobs MJ, Goldman M, et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997;40:249-60. (Pubitemid 27114088)